Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0016632 (
Fox
)
1,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
Fox
proteins are a family of regulators that control the alternative splicing of many exons in neurons, muscle, and other tissues. Each of the three mammalian paralogs,
Fox
-1 (A2BP1), Fox-2 (RBM9), and
Fox
-3 (
HRNBP3
), produces proteins with a single RNA-binding domain (RRM) flanked by N- and C-terminal domains that are highly diversified through the use of alternative promoters and alternative splicing patterns. These genes also express protein isoforms lacking the second half of the RRM (FoxDeltaRRM), due to the skipping of a highly conserved 93-nt exon.
Fox
binding elements overlap the splice sites of these exons in
Fox
-1 and Fox-2, and the
Fox
proteins themselves inhibit exon inclusion. Unlike other cases of splicing autoregulation by RNA-binding proteins, skipping the RRM exon creates an in-frame deletion in the mRNA to produce a stable protein. These FoxDeltaRRM isoforms expressed from cDNA exhibit highly reduced binding to RNA in vivo. However, we show that they can act as repressors of
Fox
-dependent splicing, presumably by competing with full-length
Fox
isoforms for interaction with other splicing factors. Interestingly, the Drosophila
Fox
homolog contains a nearly identical exon in its RRM domain that also has flanking
Fox
-binding sites. Thus, rather than autoregulation of splicing controlling the abundance of the regulator, the
Fox
proteins use a highly conserved mechanism of splicing autoregulation to control production of a dominant negative isoform.
...
PMID:Autoregulation of Fox protein expression to produce dominant negative splicing factors. 2004 73